Aspergillus Nidulans

Generic Name: aspergillus nidulans

Over-the-Counter (OTC)

Brand Names:

Dosage form: LIQUID. Route: PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: ASPERGILLUS NIDULANS (.1 g/mL). Category: BLA.

Overview

Dosage form: LIQUID. Route: PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: ASPERGILLUS NIDULANS (.1 g/mL). Category: BLA.

Dosage

Available as liquid for percutaneous, subcutaneous use.

Related Medications

Arsenicum Album, Berberis Vulgaris, Calcarea Carbonica, Candida Albicans, Carbo Vegetabilis, Chelidonium Majus, Echinacea Purpurea, Hepar Sulphuris Calcareum, Kreosotum, Lycopodium Clavatum, Mercurius Solubilis, Muriaticum Acidum, Nitricum Acidum, Oxalicum Acidum, Sepia Officinalis, Sulphur

arsenicum album, berberis vulgaris, calcarea carbonica, candida albicans, carbo vegetabilis, chelidonium majus, echinacea purpurea, hepar sulphuris calcareum, kreosotum, lycopodium clavatum, mercurius solubilis, muriaticum acidum, nitricum acidum, oxalicum acidum, sepia officinalis, sulphur

Non-Standardized Fungal Allergenic Extract [EPC]

Uses For the temporary relief of symptoms associated with minor fungal, viral and bacterial infections.

Lisdexamfetamine Dimesylate

lisdexamfetamine dimesylate

Lisdexamfetamine dimesylate is a CNS stimulant available as capsules for once-daily oral administration, indicated for the treatment of ADHD in patients 6 years and older and moderate to severe binge eating disorder in adults.

Sacituzumab Govitecan

sacituzumab govitecan

11 DESCRIPTION Sacituzumab govitecan-hziy is a Trop-2 directed antibody and topoisomerase inhibitor conjugate, composed of the following three components: the humanized monoclonal antibody, hRS7 IgG1κ (also called sacituzumab), which binds to Trop-2 (the trophoblast cell-surface antigen-2); the drug SN-38, a topoisomerase inhibitor; a hydrolysable linker (called CL2A), which links the humanized monoclonal antibody to SN-38.

Medical Disclaimer

This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.